FMR1 GENE POLYMORPHISM IN POLYCYSTIC OVARY SYNDROME
- Authors: Tabeeva G.I1, Nemova Y.I1, Naidukova A.A1, Kuznetsova E.B2, Zaletaev D.B2, Chernukha G.E1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- Issue: No 3 (2016)
- Pages: 50-57
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247648
- ID: 247648
Cite item
Abstract
Full Text
About the authors
G. I Tabeeva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: bambine@mail.ru
MD, PhD, researcher at the Department of Gynecological Endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
Yu. I Nemova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: j_nemova@hoonail.com
graduate student of department of gynecological endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
A. A Naidukova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: aleeshla@mail.ru
post-graduate department of gynecological endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
E. B Kuznetsova
I.M. Sechenov First Moscow State Medical University
Email: kuznetsova.k@bk.ru
Ph.D., Leading Researcher, Laboratory of Human Molecular Genetics Moscow 119048, Trubetskaya str. 8, bid. 2, Russia
D. B Zaletaev
I.M. Sechenov First Moscow State Medical UniversityPh.D., Professor, Head of Laboratory of Human Molecular Genetics Moscow 119048, Trubetskaya str. 8, bid. 2, Russia
G. E Chernukha
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of RussiaMD, Professor, Head of the Department of Gynecological Endocrinology Moscow 117997, Ac. Oparina str. 4, Russia
References
- Fauser В.C., Tarlatzis В.С., Rebar R.W., Legro R.S., Balen A.H., Lobo R. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 2012; 97(1): 28-38. e25.
- Legro R.S., Modi B.P., Strauss J.F., McAllister J.M., 3rd. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol. Metab. 2015; 26(3): 118-24. doi: 10.1016/j.tem.2014.12.004.
- Gleicher N., Weghofer A., Barad D.H. Effects of race/ethnicity on triple CGG counts on FMR1 gene in infertile women and egg donors. Reprod. Biomed. Online. 2010; 20(4): 485-91.
- Hoffman G.E., Le W.W., Entezam A., Otsuka N., Tong Z.B., Nelson L. et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J. Histochem. Cytochem. 2012; 60(6): 439-56.
- Lu C., Lin L., Tan H., Wu H., Sherman S.L., Gao F. et al. Fragile X permutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum. Mol. Genet. 2012; 21(23): 5039-47.
- Conway G.S. Premature ovarian failure and FMR1 gene mutations: an update. Ann. Endocrinol. (Paris). 2010; 71(3): 215-7.
- Gleicher N., Weghofer A., Lee I.H., Barad D.H. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One. 2010; 5(12): ЄІ5303.
- Barad D.H., Weghofer A., Goyal A., Gleicher N. Further refinement in defining the effect of heterozygous-abnormal egg counts on the FMR1 (Fragile X) gene: definition of a distinct subgroup of PCOS patient, based on norma/low genotype. Fertil. Steril. 2009; 92(3, Suppl.): S105.
- Rotterdam ESHRE/ASMR-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertil. Steril. 2004; 81(1): 19-26.
- Shamilova N.N., Marchenko L.A., Dolgushina N. V., ZaletaevD. V., Sukhikh G. T The role of genetic and autoimmune factors in premature ovarian failure. J. Assist. Reprod. Genet. 2013; 30(5): 617-22.
- Gleicher N., Weghover A., Oktay K., Barad D.H. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet. Gynecol. Scand. 2009; 88(9): 1024-30.
- Spath M.A., Feuch T.B., Allen E.G., SmitsA.P., YntemaH.G., van Kessei A.G. et al. Intra-indinidual stability over time of standardardized anti- Mullerian hormone in FMR1 premutation carries. Hum. Reprod. 2011; 26(8): 2185- 91.
- Choe S.A., Кіт K.C., Lee J.Y., Кіт C.H., Hwang D., Jee B.C. The relation between the number of CGG repeats and serum level of anti-Mullerian hormone in women without FMR1 premutation. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 169(2): 275-8.
- DeGeyter C., M’Rabet N., DeGeyter J., Ziircher S., Moffat R., Bosch N. et al. Similar prevalence of expanded CGG repeat length sinthe fragile X mental retardation I gene among infertile women and among women with provenfertility: a prospective study. Genet. Med. 2014; 16(5): 374-8.
- Kline J., Kinney A., Kelly A., Reuss M.L., Levin B. Predictors of antral follicle count during the reproductive years. Hum. Reprod. 2005; 20(8): 2179-89.
- Rohr J., Allen E.G., Charen K., Giles J., He W., Dominguez C. et al. Anti- Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 2008; 23: 1220-5.
- Pastore L.M., Young S.L., Baker V.L., Karns L.B., Williams C.D., Silverman L.M. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod. Sci. 2012; 19(11): 1226-31.
- Gleicher N., Weghofer A., Barad D.H. Ovarian reserve determinations suggest new function of FMR1 (fragile X) gene in regulating ovarian aging. Reprod. Biomed. Online. 2010; 20(6): 768-75.
- Gleicher N., Kushnir V.A., Weghofer A., Barad D.H. How the FMR1 gene became relevant to female fertility and reproductive medicine. Front. Genet. 2014; 5: 284.
- Ванян З.Э. Клинико-диагностическое значение аутоиммунных и генетических факторов при “бедном” овариальном ответе на стимуляцию суперовуляции в программах вспомогательных репродуктивных технологий: автореф. дисс.. канд. мед. наук. М.; 2015. 27с.